Ivermectin for Dogs: Uses, Safety, and the MDR1 Risk

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-19

Ivermectin is a broad-spectrum antiparasitic drug that belongs to the macrocyclic lactone class. In dogs, its licensed role in the United States is narrow and specific: it is the active ingredient in monthly heartworm preventives, most often combined with pyrantel pamoate, and it works by killing the third- and fourth-stage larvae of Dirofilaria immitis before they mature into adult worms [1][2][3]. Outside that label, veterinarians use ivermectin extra-label for conditions such as sarcoptic mange and certain other external parasites [4][5][6]. The drug is generally safe at the tiny preventive dose. It becomes dangerous when the dose climbs, when a dog carries the MDR1 (ABCB1) gene mutation, or when an owner tries to measure a livestock formulation at home. This article explains what ivermectin does, how the labeled and extra-label uses differ, why the dose gap matters so much, and what every owner should know about the MDR1 risk.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance

What Ivermectin Is and How It Works

Ivermectin is one of the macrocyclic lactones, a drug class that also includes moxidectin, selamectin, and milbemycin. Macrocyclic lactones are the only drug class currently licensed for heartworm disease prophylaxis [1]. They kill the third-stage and fourth-stage larvae of Dirofilaria immitis, which prevents those larvae from developing into the adult worms that cause heartworm disease [1].

The drug works by interfering with the parasite's nervous system. In mammals, a transport protein called P-glycoprotein, encoded by the ABCB1 gene (historically called the MDR1 gene), pumps ivermectin out of the brain and keeps drug concentrations in the central nervous system low [7][11]. When that pump functions normally, a dog tolerates the drug well at appropriate doses. When the pump is defective, ivermectin accumulates in the brain and produces neurologic signs [7][12][11].

That single mechanism explains nearly everything that follows in this article. The dose, the breed, and the formulation all interact with how much drug reaches the brain.

Labeled Uses of Ivermectin in Dogs

Heartworm Prevention

The primary licensed use of ivermectin in dogs is heartworm prevention. Products such as Heartgard Plus combine ivermectin with pyrantel pamoate and are given monthly to kill heartworm larvae before they mature [2][3]. The preventive dose is extremely small. In the combination product literature, the ivermectin component is dosed at a minimum of 6 micrograms per kilogram of body weight [13][14]. That is a microgram dose, not a milligram dose, and the difference is central to understanding ivermectin safety.

Research continues to explore how these low doses behave. In one study, heartworm infective larvae collected from mosquitoes that fed on dogs receiving low-dose, short-regimen doxycycline plus ivermectin were unable to complete normal development in heartworm-naive dogs [13]. Another study examined whether a single prophylactic dose of ivermectin combined with doxycycline at various schedules could block transmission, again using the minimum 6 microgram per kilogram dose [14]. These studies reinforce that the preventive effect is achieved at a very low dose.

Long-acting formulations also exist. A subcutaneous ivermectin implant has been studied for long-term heartworm prevention, designed to release a small amount of drug continuously for at least 12 months [15]. A sustained-release implant formulation was compared with extended-release moxidectin in dogs in heartworm-endemic regions of Italy, using a minimum standard dose of 0.13 mg/kg of ivermectin [16]. These implants are a veterinary-administered option, not something an owner handles at home.

What the Labeled Product Does Not Cover

A monthly ivermectin heartworm preventive is not a general dewormer for adult intestinal parasites beyond what the label states, and it does not treat adult heartworm infection. The macrocyclic lactones kill larval stages, which is why prevention must happen before adult worms develop [1]. A dog that is already heartworm positive needs a different treatment plan managed by a veterinarian.

Extra-Label Use: Ivermectin for Mange and Other Parasites

Veterinarians use ivermectin extra-label for skin parasites, including sarcoptic mange and certain other integumentary conditions [4][5][6]. This is where the dose gap becomes enormous and where most owner confusion and most toxicity cases originate.

The heartworm preventive dose is measured in micrograms per kilogram. The extra-label doses used to treat mange and similar conditions are far higher, often by an order of magnitude or more. The exact extra-label dose depends on the parasite, the dog's condition, and the veterinarian's judgment. It is not a number an owner should calculate, and it should never be used as a home dosing recipe.

The reason the gap matters is pharmacokinetic. At the tiny preventive dose, brain concentrations of ivermectin stay low even in dogs with a partially or fully defective P-glycoprotein pump. At the much higher extra-label dose, brain concentrations rise, and a dog with the MDR1 mutation can develop severe neurotoxicity [7][11]. Even dogs with normal ABCB1 genes have a ceiling, and the extra-label dose range sits much closer to that ceiling.

The Merck Veterinary Manual lists ivermectin among antiparasitic drugs used for integumentary disease in animals [5]. VCA Animal Hospitals notes ivermectin use in dogs and cats and describes it as a prescription medication with specific indications [4]. Both sources frame these uses as veterinary decisions, not owner decisions.

Why Livestock Ivermectin Products Are Dangerous to Dose at Home

Ivermectin is sold for cattle, swine, and horses as injectable and pour-on formulations. These products are concentrated for animals weighing hundreds of kilograms. An owner who tries to scale a cattle dose down to a 10-kilogram puppy is working with a formulation, a concentration, and a measurement problem that has produced countless poisonings.

Three specific problems make home dosing of livestock ivermectin dangerous.

First, the concentration. A cattle injectable may contain tens of milligrams of ivermectin per milliliter. A dog's preventive dose is measured in micrograms. The arithmetic error between those units is easy to make and catastrophic in effect.

Second, the formulation. Livestock products are not manufactured to the same purity and excipient standards as dog-labeled products, and some pour-on products contain solvents that are themselves irritating or toxic when given orally to a dog.

Third, the measurement. Even a careful owner using a syringe cannot reliably measure a microgram-scale dose from a milligram-per-milliliter concentrate. The margin between a therapeutic extra-label dose and a toxic dose is narrow, and the MDR1 status of the dog is usually unknown at the moment of dosing.

Veterinary toxicology case reports describe dogs that developed severe neurologic signs within hours of receiving ivermectin for suspected endoparasitism [8]. The clinical picture in that report, hind limb ataxia progressing to a semicomatose state, is the classic presentation of ivermectin toxicosis. It is not a picture any owner should risk creating at home.

The safe path is a veterinarian-prescribed product with a known concentration, a known dose, and a known MDR1 status when that status is relevant.

The MDR1 (ABCB1) Mutation: The Core Safety Issue

What the Mutation Does

The MDR1 gene, now correctly called ABCB1, encodes P-glycoprotein. This protein sits in the blood-brain barrier and pumps certain drugs, including ivermectin, out of the central nervous system [7][11]. A specific four-base pair deletion mutation in the ABCB1 gene produces a truncated, nonfunctional P-glycoprotein [7][17][11]. Dogs that inherit two copies of the mutation (homozygous) have essentially no functional pump at the blood-brain barrier. Dogs with one copy (heterozygous) have reduced function and intermediate risk.

The mutation is a deletion of four base pairs, described in the literature as c.296-299delAGAT or nt230(del4) [18][11]. A PCR-based diagnostic test can distinguish homozygous normal, heterozygous carrier, and homozygous mutant dogs from a small blood sample [11]. This is the test veterinarians use when a dog's breed or history raises concern.

How the Mutation Was Traced

The mutation is not random. A 2004 study used breed phylogeny and drug-sensitivity reports to survey purebred populations and found the same allele, mdr1-1Delta, segregating in nine breeds, including two sighthounds that were not expected to share collie ancestry [19]. A conserved mutant haplotype across affected breeds indicated the allele was identical by descent. The authors concluded that all dogs carrying the mutation descend from a dog that lived in Great Britain before breeds were genetically isolated by registry around 1873 [19]. The mutation marks the emergence of formally recognized breeds from an admixed population of working sheepdogs [19].

Which Breeds Carry the Mutation

The classic breeds are the Collie and related herding breeds. A Belgian study assessed the ABCB1 genotype in 92 dogs of breeds suspected to carry the deletion and found the mutation in the Australian Shepherd, Collie, Shetland Sheepdog, and Swiss White Shepherd. It was not detected in the Bearded Collies, Border Collies, and German Shepherds in that study, which matched findings in similar breed populations in other countries [7].

An Australian study genotyped Collies, Australian Shepherds, Border Collies, and Shelties. The mutation was identified in Collies, Australian Shepherds, and Shelties but not in the Border Collies tested, though the authors noted the Border Collie sample was small. Among the Collies, 12 percent were homozygous normal, 64 percent were carriers, and 24 percent were homozygous mutant [20]. That is a high carrier rate, which is why breed alone is a reason to test before using higher-risk drugs.

The 2004 study extended the list to nine breeds total, including the two unexpected sighthounds [19]. The practical takeaway is that the mutation is not confined to the Collie, and a veterinarian who is considering an extra-label macrocyclic lactone should know the dog's genotype.

Breeds That Appear Not to Carry It

Not every breed is at risk. A 2024 study screened 30 Kangal and 20 Akbaş dogs, two breeds native to Turkey, for the four-base deletion in the ABCB1 gene. None of the individuals carried the deletion, which the authors interpreted as preliminary evidence that these breeds are not sensitive to drugs handled by the P-glycoprotein pump, including ivermectin. The authors noted the analysis should be repeated with larger sample sizes [18]. This does not change the risk profile for Collie-lineage breeds, but it does show that breed risk is not universal.

Other Drugs Affected by the Same Mutation

The MDR1 mutation does not only affect ivermectin. Dogs homozygous for the mutation are susceptible to toxic effects from loperamide and vincristine as well [17]. A study of acepromazine sedation in rough-coated Collies found that homozygous mutant dogs had a significantly higher sedation score area under the curve than normal dogs after intravenous acepromazine, though the differences at individual time points were not statistically significant [17]. This matters because it means a dog with the mutation may respond differently to several common veterinary drugs, not just ivermectin.

A case report described an Australian Shepherd that developed clear neurotoxicity, including ataxia, crawling, acoustic and tactile hyperexcitability, and miosis, after a single dose of moxidectin at 400 micrograms per kilogram. The dog was homozygous for the MDR1 mutation [11]. Moxidectin is a different macrocyclic lactone, and this case shows the mutation affects the whole drug class.

Moxidectin as a Comparison

The safety difference between macrocyclic lactones is real. Moxidectin has a longer half-life and greater tissue distribution than ivermectin, and it has a greater margin of safety in dogs with the ABCB1 gene defect [1]. This is one reason some veterinarians prefer moxidectin-based preventives for dogs known to carry the mutation. The choice still belongs to the veterinarian, who weighs the dog's genotype, age, and parasite risk.

Ivermectin Dosage for Dogs: Why the Number Is Not Yours to Choose

Owners search for an ivermectin dosage for dogs because they want a number. The honest answer is that the number depends on the product, the indication, and the dog.

For labeled heartworm prevention, the dose is the one printed on the product label and confirmed by the prescribing veterinarian. The ivermectin component in combination preventives is dosed at a minimum of 6 micrograms per kilogram [13][14]. That is the preventive dose, and it is the only dose an owner should ever see on a home product.

For extra-label uses such as mange, the dose is higher and is set by the veterinarian based on the parasite, the dog's weight, the dog's MDR1 status, and the formulation being used [4][5][6]. There is no safe home recipe. A dog's weight in pounds must be converted to kilograms, the concentration of the specific product must be known, and the MDR1 genotype should be known before any dose above the preventive range is considered.

The reason this article does not give a home dosing recipe is not caution for its own sake. It is that the difference between a therapeutic extra-label dose and a toxic dose is small, the MDR1 status of most dogs is unknown, and the formulations available to owners are the wrong ones. A veterinarian with the right product, the right scale, and the right test can do this safely. An owner with a cattle syringe cannot.

Side Effects and Ivermectin Toxicity in Dogs

Expected Side Effects at the Labeled Dose

At the labeled preventive dose, ivermectin is generally well tolerated. Some dogs may have mild gastrointestinal upset, and individual sensitivity varies. The MDR1 mutation is the main reason a dog reacts badly to a dose that other dogs handle without incident [7][11].

Signs of Ivermectin Toxicosis

Ivermectin toxicity in dogs is a neurologic syndrome. The classic signs include:

• Ataxia, especially in the hind limbs, which may appear within two hours of exposure [8]
• Hypersalivation
• Vomiting
• Dilated pupils or miosis
• Tremors
• Disorientation or stumbling
• Depression progressing to stupor or coma [8]
• In severe cases, respiratory depression and death

A case report described a dog that developed hind limb ataxia within two hours of oral ivermectin, with neurologic signs progressing rapidly until the dog was semicomatose at admission 20 hours later. The dog improved gradually with supportive care [8]. That timeline is typical. Signs can worsen for hours before they plateau.

A retrospective study of ivermectin toxicosis in dogs documented the range of presentations seen in clinical practice [10]. A separate clinical review covers the recognition and management of ivermectin toxicosis in dogs [9]. Both sources describe a condition that requires immediate veterinary care.

Ocular Effects

Ivermectin toxicosis can affect the eye. A report described retinopathy associated with ivermectin toxicosis in two dogs [21]. Electroretinographic changes were documented after intravenous lipid emulsion therapy in a dog and a foal with ivermectin toxicosis [22]. These findings mean that a dog recovering from ivermectin toxicity may need ophthalmologic evaluation, not just neurologic monitoring.

What to Do If You Suspect Toxicity

If a dog shows neurologic signs after receiving ivermectin, treat it as an emergency. Call a veterinarian or an animal poison control service immediately. Do not wait to see if the signs improve. Bring the product container, so the veterinarian knows the concentration and the amount given.

Treatment of Ivermectin Toxicosis

There is no specific antidote that reverses ivermectin toxicity. Treatment is supportive and aimed at limiting further drug absorption and supporting the dog until the drug clears.

Decontamination and Supportive Care

If the exposure was recent and the dog is stable, a veterinarian may induce vomiting or administer activated charcoal to reduce absorption. Supportive care includes intravenous fluids, temperature management, and monitoring of respiration and cardiovascular function. Dogs that cannot breathe adequately may need mechanical ventilation.

Intravenous Lipid Emulsion

Intravenous lipid emulsion therapy has been used as a treatment for ivermectin toxicosis. A case series described its use in three dogs homozygous for the ABCB1-1Delta mutation [23]. A separate report documented electroretinographic changes after intravenous lipid emulsion therapy in a dog and a foal with ivermectin toxicosis [22]. Lipid emulsion is thought to act as a lipid sink that draws lipophilic drug out of tissues, though the exact mechanism and the degree of benefit vary by case. It is a hospital treatment, not something an owner can administer.

Physostigmine

Physostigmine has been studied as a treatment for ivermectin toxicosis. A 1987 study examined the response to physostigmine administration in Collie dogs exhibiting ivermectin toxicosis [24]. Physostigmine is not a routine first-line treatment and is used at the veterinarian's discretion.

Recovery

Recovery depends on the dose, the dog's MDR1 status, and how quickly treatment starts. The dog in the case report improved gradually under supportive care [8]. Dogs that survive the acute phase generally recover, but the process can take days.

Drug Interactions and Combination Risks

Spinosad

Spinosad is an insecticide used in some flea products. When spinosad is combined with high-dose, extra-label ivermectin, the risk of neurotoxicity increases. The interaction is relevant because spinosad can enhance the penetration of ivermectin into the central nervous system. A veterinarian who is considering extra-label ivermectin should know whether the dog is receiving spinosad.

Other P-Glycoprotein Substrates

Because the MDR1 mutation affects P-glycoprotein function broadly, other drugs handled by the same pump can interact. Loperamide, an over-the-counter antidiarrheal, and vincristine, a chemotherapy drug, are both associated with toxicity in MDR1-mutant dogs [17]. Acepromazine sedation is prolonged in these dogs [17]. Moxidectin, another macrocyclic lactone, has caused neurotoxicity in a homozygous mutant dog [11].

The practical rule is that a dog with a known or suspected MDR1 mutation should have every new medication reviewed by a veterinarian before it is given.

Heartworm Preventive Combinations

Ivermectin is commonly combined with pyrantel pamoate in heartworm preventives [2][3]. This combination is well established and is dosed at the labeled preventive rate. The combination itself is not the risk. The risk comes from adding extra-label ivermectin on top of a preventive, or from using a livestock product instead of the labeled one.

How Ivermectin Compares With Other Options

Moxidectin

Moxidectin is the closest comparator. It has a longer half-life and greater tissue distribution than ivermectin, and it has a greater margin of safety in dogs with the ABCB1 gene defect [1]. Multiple laboratory studies have shown moxidectin is more effective than other commonly used heartworm preventives against resistant strains of D. immitis [1]. For a dog known to carry the MDR1 mutation, moxidectin-based prevention is often the safer choice, though the decision belongs to the veterinarian.

Other Macrocyclic Lactones

Selamectin and milbemycin are also macrocyclic lactones used in parasite control. They share the same general mechanism and the same theoretical interaction with P-glycoprotein, though their individual safety profiles differ.

Non-Macrocyclic Options

For some parasites, non-macrocyclic drugs are available. The choice depends on the parasite, the dog's health, and the veterinarian's assessment. There is no single best answer for every dog.

Questions to Ask Your Veterinarian

Before starting or changing any ivermectin product, ask:

• Is this product labeled for heartworm prevention, or is it an extra-label use?
• What is the exact dose, and how was it calculated for my dog's weight?
• Does my dog's breed carry the MDR1 mutation, and should we test?
• Is my dog currently on spinosad or any other medication that could interact?
• What signs should I watch for at home, and when should I call?
• How often should we recheck, and what tests will be done?
• Is there a safer alternative for my dog's specific risk profile?

Limitations and When to Contact a Veterinarian

This article covers the general principles of ivermectin use in dogs. It cannot account for your dog's individual weight, breed, genotype, other medications, or current health. Every dosing decision belongs to a veterinarian who has examined your dog.

Contact a veterinarian immediately if your dog shows any of the following after receiving ivermectin:

• Hind limb weakness, wobbling, or inability to stand
• Tremors, twitching, or seizures
• Excessive salivation or vomiting
• Dilated pupils, unusual eye movements, or apparent blindness
• Disorientation, depression, or unresponsiveness
• Difficulty breathing

Do not wait for signs to resolve on their own. Ivermectin toxicosis can progress from mild ataxia to coma within hours [8]. Early treatment improves the outcome.

If you are considering an extra-label ivermectin product for mange or another skin condition, do not start it without a veterinarian's guidance. Ask about MDR1 testing first, especially if your dog is a Collie, Australian Shepherd, Shetland Sheepdog, Swiss White Shepherd, or any breed with collie lineage [7][19][20].

Frequently Asked Questions

Is ivermectin safe for dogs?

Ivermectin is safe for most dogs at the labeled heartworm preventive dose, which is measured in micrograms per kilogram [13][14]. The main exception is dogs carrying the MDR1 (ABCB1) mutation, which makes them far more sensitive to the drug's neurologic effects [7][11]. Safety depends on the dose, the formulation, and the dog's genotype.

What is the ivermectin dosage for dogs?

The labeled heartworm preventive dose for the ivermectin component is a minimum of 6 micrograms per kilogram [13][14]. Extra-label doses for conditions such as mange are higher and are set by a veterinarian based on the individual dog [4][5][6]. There is no safe home dosing recipe for extra-label use.

What are the signs of ivermectin toxicity in dogs?

The classic signs are neurologic. They include hind limb ataxia, which can appear within two hours of exposure, hypersalivation, vomiting, tremors, dilated pupils, disorientation, and progression to stupor or coma [8][9][10]. Retinopathy and abnormal electroretinographic findings have also been reported [21][22]. Any of these signs after ivermectin exposure is an emergency.

What is the MDR1 gene in dogs?

The MDR1 gene, now called ABCB1, encodes P-glycoprotein, a protein that pumps drugs such as ivermectin out of the brain [7][11]. A four-base pair deletion mutation produces a nonfunctional pump, so the drug accumulates in the central nervous system and causes toxicity [7][17][11]. Dogs with two copies of the mutation are at highest risk.

Which dog breeds carry the MDR1 mutation?

The mutation is found in Collies, Australian Shepherds, Shetland Sheepdogs, and Swiss White Shepherds, and it has been traced to nine breeds total, including two sighthounds [7][19]. A 2004 study concluded that all carriers descend from a dog that lived in Great Britain before breeds were isolated by registry around 1873 [19]. Kangal and Akbaş dogs were not found to carry the deletion in a preliminary 2024 study [18].

Can I use livestock ivermectin on my dog?

No. Livestock ivermectin products are concentrated for animals weighing hundreds of kilograms, and the concentration, formulation, and measurement problems make home dosing dangerous. A dog's preventive dose is measured in micrograms, while cattle products are measured in milligrams per milliliter. Poisonings from this mistake are well documented in the veterinary literature [8][9][10].

How is ivermectin toxicity treated in dogs?

Treatment is supportive and includes decontamination when appropriate, intravenous fluids, and monitoring of respiration and cardiovascular function. Intravenous lipid emulsion has been used in affected dogs, including three dogs homozygous for the ABCB1-1Delta mutation [23][22]. Physostigmine has also been studied in Collies with ivermectin toxicosis [24]. There is no specific antidote, and hospital care is required.

Is ivermectin used for mange in dogs?

Yes, veterinarians use ivermectin extra-label for sarcoptic mange and certain other skin parasites [4][5][6]. The dose is much higher than the heartworm preventive dose, which is why MDR1 testing and veterinary supervision matter. Do not attempt this treatment at home.

Related Articles

• Can You Give Your Dog Imodium? Dosage and Safety Guide
• Can You Give Your Dog Zyrtec for Allergies? Dosage and Safety
• Can You Give Your Dog Melatonin for Anxiety? Safety and Dosage
• Can I Give My Dog Benadryl? Safe Dosage and When to Avoid
• Mange In Dogs
• Can You Give Your Dog Dramamine for Motion Sickness? Dosage and Safety
• Denamarin for Dogs: Uses, How to Give It, and Evidence
• Capstar for Dogs and Cats: How Fast It Works, Dose, Safety
• Frontline Plus for Dogs and Cats: How It Works and Does It Still Work

Sources

1. A review of moxidectin vs. other macrocyclic lactones for prevention of heartworm disease in dogs with an appraisal of two commercial formulations
2. Ivermectin + Pyrantel (vcahospitals.com)
3. HEARTGARD® PLUS (ivermectin/pyrantel) (dailymed.nlm.nih.gov)
4. Ivermectin for Dogs and Cats (vcahospitals.com)
5. Antiparasitic Drugs for Integumentary Disease in Animals (merckvetmanual.com)
6. Ivermectin (Ivomec, Heartgard 30, Iverheart Plus) (veterinarypartner.vin.com)
7. Presence of the ABCB1 (MDR1) deletion mutation causing ivermectin hypersensitivity in certain dog breeds in Belgium
8. Ivermectin toxicosis in a dog.
9. Ivermectin Toxicosis in Dogs
10. Ivermectin toxicosis in dogs: a retrospective study.
11. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd.
12. Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.
13. Inability of Dirofilaria immitis infective larvae from mosquitoes fed on blood from microfilaremic dogs during low-dose and short-treatment regimens of doxycycline and ivermectin to complete normal development in heartworm naïve dogs.
14. Blocking Dirofilaria immitis transmission by treatment of heartworm microfilaremic dogs with doxycycline.
15. Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs.
16. Efficacy and safety of a sustained-release formulation of ivermectin (FILAPREV®) in preventing heartworm infection (Dirofilaria immitis) in dogs in two endemic areas of Italy.
17. The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine
18. Investigation of Ivermectin Susceptibility in Kangal and Akbaş Dogs via MDR1 Gene Mutation
19. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
20. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia.
21. Retinopathy associated with ivermectin toxicosis in two dogs
22. Electroretinographic changes after intravenous lipid emulsion therapy in a dog and a foal with ivermectin toxicosis.
23. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.
24. Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis.